Long-COVID symptoms persist for two years in over half of cases

23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.

Core One Labs Announces Non-Brokered Private Placement | Psychedelic Invest

Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that it proposes to complete a non-brokered private

September 12, 2023

Masimo lowers outlook, citing constrained hospital budgets

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 revenue: $478.9 million

November 8, 2023

Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder | Psychedelic Invest

Vancouver, British Columbia–(Newsfile Corp. – May 30, 2024) – In a significant stride towards transforming mental health care, Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF)

May 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.